At the right time and place. While Algorithmic Biologics began to help scale the screening process for COVID-19, its seeds were laid in 2009 when Manoj, who was then a faculty member at TIFR (Tata ...

Algorithmic Biologics is a company based in Bengaluru, Karnataka, India, operating in the healthtech sector. Founded in 2021, it now employs 11 individuals. The company was established by Manoj ...

Algorithmic Biologics, a deep-tech startup building algorithms for molecular programming, today announced that it has received Conformité Européene (CE) Mark approval for its proprietary ...

New Delhi [India], February 5: Deeptech startup Algorithmic Biologics (AlgoBio), leveraging advanced algorithms and AI to revolutionize molecular testing efficiency and scale, unveiled the ...

Deep-tech start-up Algorithmic Biologics Pvt Ltd (ABPL) has received an undisclosed amount of seed funding from Axilor Lab. Algorithmic Biologics plans to deploy the fresh capital to scale its ...

Deeptech startup Algorithmic Biologics Pvt. Ltd (AlgoBio) has raised $2.5 million (Rs 20.7 crore) in a pre-Series A funding round led by Bharat Innovation Fund (BIF). The round also saw participation ...

Bengaluru (Karnataka) [India], January 11 (ANI/BusinessWire India): Algorithmic Biologics Pvt Ltd. (ABPL), a deep-tech startup building algorithms for molecular programming, today announced that ...

Geneious Biologics Annotation Algorithm Beats IgBLAST, MiXCR Says New White Paper. May 01, 2018 08:30 AM Eastern Daylight Time. AUCKLAND, New Zealand-- ...

Algorithmic Biologics, a deep-tech startup building algorithms for molecular programming, today announced that it has received Conformité Européene (CE) Mark approval for its proprietary ...

Algorithmic Biologics Pvt Ltd. (ABPL), a deep-tech startup building algorithms for molecular programming, today announced that it has received an undisclosed amount of seed funding from Axilor ...

Algorithmic Biologics plans to use the funds to unlock and scale these applications commercially, as well as extend their IP portfolio to create more building blocks of molecular technologies ...